HR 7352 · 119th Congress · Health
PASTEUR Act of 2026
Bill Progress
✓
Introduced2
Committee3
House Vote4
Senate5
EnactedLatest: Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.(2026-02-04)
Plain Language Summary
[AI summary unavailable — showing source text]
[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 7352 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 7352 To amend the Public Health Service Act to establish a program to develop innovative antimicrobial drugs targeting the most challenging pathogens and most threatening infections, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES February 4, 2026 Mr. Carter of Georgia (for himself, Mr. Peters, Mr. Langworthy, Mr. Levin, and Mr. Carey) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned _______________________________________________________________________ A BILL To amend the Public Health Service Act to establish a program to develop innovative antimicrobial drugs targeting the most challenging pathogens and most threatening infections, and for other purposes. Be it enacted by the Senate and…
Summarized by Claude AI · Non-partisan · For informational purposes only
Cosponsors (16)
8 Democrats8 Republicans